“Age reduction” is up to 6 years! A new drug has made it into Nature due to its anti-aging potential, developed through AI-assisted design.
The AI-designed drug Rentosertib shows a reduction in biological age in patients with idiopathic pulmonary fibrosis; validation and regulatory approval are still pending in healthy individuals.
A biotech company recently announced that the new drug Rentosertib, identified using artificial intelligence technology, demonstrated significant anti-aging potential in cell experiments. The research results showed that this compound can effectively reduce levels of biomarkers associated with aging; some reports even described its effect as capable of “reversing aging” by up to 6 years. Currently, relevant clinical data have not been released, and this technology is still in the early research stage, but it shows promising potential in exploring mechanisms of anti-aging.
Alex ZhavoronkovBiotechInSilicon IntelligenceNature BiotechnologyRentosertibWestlake University
Event frameEVENT FRAME
Research
AI · 中外媒体across 2 days
Status
The AI-designed drug Rentosertib shows a reduction in biological age in patients with idiopathic pulmonary fibrosis; validation and regulatory approval are still pending in healthy individuals.
Coverage · reports per dayLANGUAGE SPLIT
Coverage mixSOURCE MIX
Chinese media 2English media 1
Entity relations
Integrated timelineUNIFIED TIMELINE
2026-09-07
AI identified drugs that reverse aging markers
The biotech company announced the research results: the new compounds screened by AI can effectively reduce levels of biomarkers related to aging in cell experiments.
2026-09-08
The new drug was featured in Nature due to its potential for anti-aging effects.
The AI-designed drug Rentosertib shows significant anti-aging effects in cell experiments and mid-phase clinical trials; some reports suggest it can reduce age by up to 6 years.
The biotech company stated that a study found that AI-identified drugs can reverse aging markers. The study utilized artificial intelligence to screen and identify a new compound, and results showed that it could effectively reduce the levels of biological markers associated with aging in cell experiments. Relevant clinical data have not yet been published, but this technology demonstrates potential applications in exploring mechanisms of aging prevention.